ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01670877
Brief Title: Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

First Submitted : August 17, 2012
First Submitted that Met QC Criteria : August 17, 2012
First Posted : August 22, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : July 20, 2018
Last Update Posted : July 23, 2018